Duration of bisphosphonate treatment: results of a non-randomised study in patients previously treated with local irradiation for bone metastases from breast cancer

Local Irradiation ◽

Treatment Results ◽

Randomised Study ◽

The incidence of atypical femoral fractures in breast cancer patients with bone metastases who received bisphosphonate treatment

Journal of Orthopaedic Science ◽

10.1016/j.jos.2017.04.011 ◽

2017 ◽

Vol 22 (5) ◽

pp. 946-950 ◽

Cited By ~ 3

Author(s):

Eiji Nakata ◽

Shinsuke Sugihara ◽

Natsumi Yamashita ◽

Shozo Osumi

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Femoral Fractures ◽

Breast Cancer Patients ◽

Atypical Femoral Fractures

P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.

10.1158/0008-5472.sabcs11-p3-16-07 ◽

2011 ◽

Cited By ~ 7

Author(s):

AT Stopeck ◽

A Lipton ◽

M Martin ◽

J-J Body ◽

A Paterson ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Treatment Phase ◽

Open Label ◽

Phase 3 ◽

Pivotal Phase ◽

Open Label Extension ◽

Effect of Long-Term Bisphosphonate Treatment on Morbidity Due To Bone Metastases in Breast Cancer Patients

Recent Results in Cancer Research - Bisphosphonates and Tumor Osteolysis ◽

10.1007/978-3-642-83668-8_7 ◽

1989 ◽

pp. 73-78 ◽

Cited By ~ 10

Author(s):

F. J. Cleton ◽

A. T. van Holten-Verzantvoort ◽

O. L. M. Bijvoet

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Breast Cancer Patients

The effects of intravenous bisphosphonate treatment on the bone microenvironment in patients with breast cancer and bone metastases

European Journal of Cancer ◽

10.1016/s0959-8049(01)80965-5 ◽

2001 ◽

Vol 37 ◽

pp. S129 ◽

Cited By ~ 2

Author(s):

S.P. Jagdev ◽

P.I. Croucher ◽

R.E. Coleman

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Bone Microenvironment ◽

Intravenous Bisphosphonate

A CASE OF DELAYED ONSET OF OSTEONECROSIS OF THE JAW IN ASSOCIATION WITH BISPHOSPHONATE TREATMENT FOR BONE METASTASES FROM BREAST CANCER

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ◽

10.3919/jjsa.70.1319 ◽

2009 ◽

Vol 70 (5) ◽

pp. 1319-1322

Author(s):

Shigemi ONOUE ◽

Takao KUNO ◽

Katsushi YOSHIDA ◽

Norimasa KOIDE ◽

Yuji TORIMOTO ◽

...

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Osteonecrosis Of The Jaw ◽

Delayed Onset

Dasatinib treatment results in a markedly diminished frequency of bone metastases after intracardiac injection of osteotropic MDA-MB-231 breast cancer cells in a xenograft mouse model

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1593292 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

T Heilmann ◽

M Roscher ◽

AL Rumpf ◽

M Gerle ◽

M Tietgen ◽

...

Keyword(s):

Breast Cancer ◽

Mouse Model ◽

Bone Metastases ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Treatment Results ◽

Xenograft Mouse Model ◽

Intracardiac Injection ◽

Dasatinib Treatment

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

European Journal of Cancer ◽

10.1016/j.ejca.2012.02.016 ◽

2012 ◽

Vol 48 ◽

pp. S3 ◽

Cited By ~ 1

Author(s):

A.T. Stopeck ◽

A. Lipton ◽

M. Martín ◽

J-J. Body ◽

A. Paterson ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Treatment Phase ◽

Open Label ◽

Phase 3 ◽

Pivotal Phase ◽

Open Label Extension ◽

Gemcitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Evaluation of response toxicity

European Journal of Cancer ◽

10.1016/s0959-8049(02)80224-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

G Lerzo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Impact of decalcification on prognostic/predictive indicators in bone metastases from breast cancer. An experimental study

10.26226/morressier.5b4709876f4cb30010951ac0 ◽

2018 ◽

Author(s):

Luca Ventura

Keyword(s):

Breast Cancer ◽

Experimental Study ◽

Bone Metastases ◽

Predictive Indicators

Faculty Opinions recommendation of Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958301.793464607 ◽

2012 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Advanced Breast Cancer ◽

Bone Metastases ◽

Advanced Breast ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Pain Outcomes